M. Wakabayashi

T. Terasima1
1T. Terasima
Learn More
Studies of cell inactivation kinetics by anticancer agents are important in providing a rational basis for treatment schedules. For several years, we have reported various aspects of the survival response of mammalian cells to Bleomycin (BLM) (Terasima et al., 1972; Takabe et al., 1977). The dose-survival response of cells to BLM was characterized by an(More)
  • 1